Genetic testing in antiplatelet therapy - not effective for perioperative bleeding.
作者信息
Kuliczkowski Wiktor
机构信息
Department of Cardiology, Wroclaw Medical University, Wroclaw, Poland.
出版信息
Postepy Kardiol Interwencyjnej. 2017;13(3):187-188. doi: 10.5114/aic.2017.70184. Epub 2017 Sep 25.
Abstract
摘要
相似文献
1
Genetic testing in antiplatelet therapy - not effective for perioperative bleeding.抗血小板治疗中的基因检测——对围手术期出血无效。
Postepy Kardiol Interwencyjnej. 2017;13(3):187-188. doi: 10.5114/aic.2017.70184. Epub 2017 Sep 25.
2
Perioperative Outcomes Following Partial Nephrectomy Performed on Patients Remaining on Antiplatelet Therapy.抗血小板治疗患者行部分肾切除术的围手术期结局。
J Urol. 2017 Jan;197(1):31-36. doi: 10.1016/j.juro.2016.07.001. Epub 2016 Jul 11.
3
Prospective observational cohort study of the association between antiplatelet therapy, bleeding and thrombosis in patients with coronary stents undergoing noncardiac surgery.前瞻性观察性队列研究抗血小板治疗与冠状动脉支架置入术后非心脏手术患者出血和血栓形成的关系。
Br J Anaesth. 2019 Feb;122(2):170-179. doi: 10.1016/j.bja.2018.09.029. Epub 2018 Dec 15.
4
Perioperative management of oral antiplatelet therapy and clinical outcomes in coronary stent patients undergoing surgery. Results of a multicentre registry.接受手术的冠状动脉支架植入患者围手术期口服抗血小板治疗的管理及临床结局。一项多中心注册研究的结果
Thromb Haemost. 2015 Feb;113(2):272-82. doi: 10.1160/TH14-05-0436. Epub 2014 Oct 2.
6
Different perioperative antiplatelet therapies for patients treated with carotid endarterectomy in routine practice.常规实践中接受颈动脉内膜切除术患者的不同围手术期抗血小板治疗。
J Vasc Surg. 2018 Dec;68(6):1753-1763. doi: 10.1016/j.jvs.2018.01.063. Epub 2018 Jul 29.
7
[Perioperative anti-platelet therapy management--protocol suggestion].
Harefuah. 2011 Apr;150(4):327-32, 421, 420.
8
The safe and risk assessment of perioperative antiplatelet and anticoagulation therapy in inguinal hernia repair, a systematic review.腹股沟疝修补术围手术期抗血小板和抗凝治疗的安全性和风险评估：系统评价。
Surg Endosc. 2019 Oct;33(10):3165-3176. doi: 10.1007/s00464-019-06956-y. Epub 2019 Jul 15.
9
Risk of bleeding in patients with continued dual antiplatelet therapy during orthopedic surgery.骨科手术中继续双联抗血小板治疗患者的出血风险。
Chin Med J (Engl). 2019 Apr 20;132(8):943-947. doi: 10.1097/CM9.0000000000000186.
10
Management of antiplatelet therapy for non-elective invasive procedures or bleeding complications: Proposals from the French Working Group on Perioperative Haemostasis (GIHP) and the French Study Group on Thrombosis and Haemostasis (GFHT), in collaboration with the French Society for Anaesthesia and Intensive Care (SFAR).择期侵入性操作或出血并发症的抗血小板治疗管理：法国围手术期止血工作组（GIHP）和法国血栓与止血研究组（GFHT）与法国麻醉与重症监护学会（SFAR）合作提出的建议。
Arch Cardiovasc Dis. 2019 Mar;112(3):199-216. doi: 10.1016/j.acvd.2018.10.004. Epub 2019 Jan 6.
本文引用的文献
1
Association of polymorphisms of platelet receptors GPIa (807C>T), GPVI (13254T>C), and P2Y12 (34C>T and H1/H2 haplotype) with increased risk of periprocedural bleeding in patients undergoing coronary angiography/percutaneous coronary intervention.血小板受体GPIa（807C>T）、GPVI（13254T>C）和P2Y12（34C>T及H1/H2单倍型）多态性与接受冠状动脉造影/经皮冠状动脉介入治疗患者围手术期出血风险增加的相关性。
Postepy Kardiol Interwencyjnej. 2017;13(3):202-209. doi: 10.5114/aic.2017.70187. Epub 2017 Sep 25.
2
Radial vs Femoral Approach in Acute Coronary Syndromes: A Meta- Analysis of Randomized Trials.径向与股动脉入路在急性冠状动脉综合征中的比较：一项随机试验的荟萃分析。
Curr Vasc Pharmacol. 2017;16(1):79-92. doi: 10.2174/1570161115666170504125831.
3
Access-site bleeding and radial artery occlusion in transradial primary percutaneous coronary intervention: influence of adjunctive antiplatelet therapy.经桡动脉直接经皮冠状动脉介入治疗中的穿刺部位出血和桡动脉闭塞：辅助抗血小板治疗的影响
Coron Artery Dis. 2016 Jun;27(4):267-72. doi: 10.1097/MCA.0000000000000352.
4
Personalized antiplatelet therapy with P2Y12 receptor inhibitors: benefits and pitfalls.使用P2Y12受体抑制剂的个性化抗血小板治疗：益处与陷阱
Postepy Kardiol Interwencyjnej. 2015;11(4):259-80. doi: 10.5114/pwki.2015.55596. Epub 2015 Jan 12.
5
Phenotyping vs. genotyping for prediction of clopidogrel efficacy and safety: the PEGASUS-PCI study.表型分析与基因分型预测氯吡格雷疗效和安全性：PEGASUS-PCI 研究。
J Thromb Haemost. 2012 Apr;10(4):529-42. doi: 10.1111/j.1538-7836.2012.04639.x.
6
First analysis of the relation between CYP2C19 genotype and pharmacodynamics in patients treated with ticagrelor versus clopidogrel: the ONSET/OFFSET and RESPOND genotype studies.替格瑞洛与氯吡格雷治疗患者中CYP2C19基因型与药效学关系的首次分析：ONSET/OFFSET和RESPOND基因型研究
Circ Cardiovasc Genet. 2010 Dec;3(6):556-66. doi: 10.1161/CIRCGENETICS.110.958561. Epub 2010 Nov 15.
7
Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement.细胞色素 2C19*17 等位基因变异、血小板聚集、出血事件和氯吡格雷治疗的冠状动脉支架置入患者的支架血栓形成。
Circulation. 2010 Feb 2;121(4):512-8. doi: 10.1161/CIRCULATIONAHA.109.885194. Epub 2010 Jan 18.
Zotero 插件